Quest Diagnostics (DGX) Raises Quarterly Dividend 12.5% to $0.45; 2.2% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Mizuho Securities Remains Sidelined on Quest Diagnostics (DGX) Following Investor Day
November 14, 2016 6:54 AM ESTMizuho Securities maintained a Neutral rating and $88.00 price target on Quest Diagnostics (NYSE: DGX) following the company's investor day. DGX raised its outlook for revenue growth for the period 2017-2020 to +3-5% from +2-5% previously and expects earnings for the same period to grow... More
